Latest Videos |view all videos
Mayo oral cancer study shows full tumor genome
Mayo Clinic researchers along with collaborators from Life Technologies are reporting on the application of a new approach for sequencing RNA to study cancer tumors.
An investigational drug called regorafenib slowed the progression of tumors and lengthened the lives of people with metastatic colorectal cancer, an international phase III clinical trial found.
Biopsy-based predictors of prostate cancer mortality: The Mayo Model
Matthew K. Tollefson, M.D., provides patients and clinicians with a novel way to predict which cases of prostate cancer, the most commonly diagnosed malignancy in American men, will be aggressive and which ones can be safely monitored with watchful waiting.
Grand Rounds en Español: Desarrollos Recientes en Medicina de Cáncer
Gerardo Colon-Otero, M.D., Desarrollos Recientes en Medicina de Cáncer Presentado el 25 de Septiembre, 2013 en la Clínica Mayo.
Grand Rounds (CME): Hepatitis and Liver Cancer Among Somali Immigrants in Minnesota
Abdirashid Shire, Ph.D. presents Hapatitis and Liver Cancer Among Somali Immigrants in Minnesota.
Grand Rounds: Overview of the Mayo Clinic Cancer Center
Robert B. Diasio, M.D., presents Overview of the Mayo Clinic Cancer Center.
Grand Rounds: Biorepositories and Biobanking in the Center for Individualized Medicine
Stephen N. Thibodeau, Ph.D., discusses Biorepositories and Biobanking in the Center for Individualized Medicine.
Grand Rounds: Breast Cancer Susceptibility
Fergus J. Couch, Ph.D., presents Breast Cancer Susceptibility.
Increasing incidence of melanoma among middle-aged adults
Jerry D. Brewer, M.D., M.S., discusses his article, which noted increased survival rates for incidences of melanoma, in Olmsted County, Minnesota, demonstrating early-diagnosis effectiveness.
Breakthroughs in the treatments for melanoma
Richard W. Joseph, M.D., medical oncologist at Mayo Clinic's campus in Florida, talks about the most deadly form of skin cancer, known as melanoma.
Disease Associations With MGUS — Mayo Clinic study published in Mayo Clinic Proceedings
S. Vincent Rajkumar, M.D., Mayo Clinic hematologist, discusses the first systematic study to determine association of monoclonal gammopathy of undetermined significance (MGUS) with all diseases in 17,398 patients, published in Mayo Clinic Proceedings.
Cancer and pregnancy: Parallels in growth, invasion and immune modulation
Shernan Holtan, M.D., instructor in medicine and oncology at Mayo Clinic, discusses her November 2009 Mayo Clinic Proceedings article on the parallels between cancer and pregnancy, particularly in terms of immune modulation.